Brinker Capital Investments, LLC Veracyte, Inc. Transaction History
Brinker Capital Investments, LLC
- $5.01 Billion
- Q4 2022
A detailed history of Brinker Capital Investments, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 20,724 shares of VCYT stock, worth $887,816. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,724
Previous 21,291
2.66%
Holding current value
$887,816
Previous $353,000
39.09%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding VCYT
# of Institutions
308Shares Held
81.8MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$334 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$332 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$215 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$211 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$181 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.07B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...